Ledger.Open graph →
SEC Form D · filed January 17, 2020

Acurx Pharmaceuticals, LLC

Offering
$6.0M
Sold
$455K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WHITE PLAINS, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Robert G. Shawah · White Plains, NYExecDavid P. Luci · White Plains, NYExec · DirectorRobert J. Deluccia · White Plains, NYExec · DirectorCarl G. Sailer · White Plains, NYDirectorJoanna Riley · San Francisco, CAExecRon Storn · San Francisco, CAExec · DirectorUllas Naik · San Francisco, CAExec · DirectorAnthony G. Jadhon · White Plains, NYDirectorPaul G. Baehr · White Plains, NYDirectorMark G. Rathjen · White Plains, NYDirectorMichael G. Duffy · White Plains, NYDirectorJohn G. Terrana · White Plains, NYDirectorKatie G. Jadhon · White Plains, NYDirectorThomas Lazay · Boston, MAExec · DirectorFiras Raouf · Boston, MAExecJeffrey C. Seller · NEW YORK, NYExec · DirectorCarl G. Sailer · White Plains, NYDirectorAnthony G. Jadhon · White Plains, NYDirectorPaul G. Baehr · White Plains, NYDirectorMark G. Rathjen · White Plains, NYDirectorMichael G. Duffy · White Plains, NYDirectorJohn G. Terrana · White Plains, NYDirectorKatie G. Jadhon · White Plains, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗